Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
c-KIT
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
21
42
63
84
105
126
147
168
189
210
imatinib
/ Generic mfg.
sunitinib
/ Generic mfg.
Votrient
(pazopanib) / Novartis, BeiGene
Focus V
(anlotinib) / Advenchen, Sino Biopharm
AiTan
(rivoceranib) / HLB Bio Group
sorafenib
/ Generic mfg.
Stivarga
(regorafenib) / Bayer
Cabometyx
(cabozantinib tablet) / Exelixis, Ipsen
Tasigna
(nilotinib) / Novartis, Inhibikase
Ayvakit
(avapritinib) / Blueprint Medicines
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
Qinlock
(ripretinib) / Ono Pharma
Cometriq
(cabozantinib capsule) / Exelixis, Ipsen
dasatinib
/ Generic mfg.
famitinib
(SHR 1020) / Jiangsu Hengrui Pharma
Turalio
(pexidartinib) / Daiichi Sankyo
Kinaction
(masitinib) / AB Science
dovitinib
(TKI258) / Novartis, Oncoheroes
ganetespib
(ADX-1612) / Aldeyra
bezuclastinib
(PLX9486) / Cogent Biosci
motesanib
(AMG 706) / Takeda
vatalanib
(PTK787) / Novartis, Bayer
Balversa
(erdafitinib) / J&J
Fotivda
(tivozanib) / Kyowa Kirin, Jazz, LG Chem
Iclusig
(ponatinib) / Takeda, Otsuka
chiauranib
(CS 2164) / Chipscreen
tandutinib
(MLN518) / Takeda
Nailike
(olverembatinib) / Ascentage Pharma, Takeda
XL820
/ Exelixis
sitravatinib
(MGCD516) / BeiGene
